These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 14534466)

  • 1. [Colorectal cancer: assessment of two-yearly screening of the population in health care examination centres].
    Steinmetz J; Spyckerelle Y; Giordanella JP
    Presse Med; 2003 Oct; 32(32):1496-9. PubMed ID: 14534466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Faecal occult blood screening: knowledge, attitudes, and practice in four Hong Kong primary care clinics.
    Tam TK; Ng KK; Lau CM; Lai TC; Lai WY; Tsang LC
    Hong Kong Med J; 2011 Oct; 17(5):350-7. PubMed ID: 21979470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for colorectal cancer in Italy: 2005 survey.
    Zorzi M; Barca A; Falcini F; Grazzini G; Pizzuti R; Ravaioli A; Sassoli de Bianchi P; Senore C; Sigillito A; Vettorazzi M; Visioli C
    Epidemiol Prev; 2007; 31(2-3 Suppl 2):49-60. PubMed ID: 17824362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.
    van Rossum LG; van Rijn AF; Laheij RJ; van Oijen MG; Fockens P; van Krieken HH; Verbeek AL; Jansen JB; Dekker E
    Gastroenterology; 2008 Jul; 135(1):82-90. PubMed ID: 18482589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of colonoscopy in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy).
    Zorzi M; Senore C; Da Re F; Barca A; Bonelli LA; Cannizzaro R; Fasoli R; Di Furia L; Di Giulio E; Mantellini P; Naldoni C; Sassatelli R; Rex D; Hassan C; Zappa M;
    Gut; 2015 Sep; 64(9):1389-96. PubMed ID: 25227521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colonoscopy: a review of its yield for cancers and adenomas by indication.
    Rex DK
    Am J Gastroenterol; 1995 Mar; 90(3):353-65. PubMed ID: 7872270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of immunochemical faecal occult blood test in colorectal cancer screening in average-risk population according to positivity threshold and number of samples.
    Guittet L; Bouvier V; Mariotte N; Vallee JP; Levillain R; Tichet J; Launoy G
    Int J Cancer; 2009 Sep; 125(5):1127-33. PubMed ID: 19431212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Screening for colorectal cancer. Study of a population attending a public health clinic].
    Steinmetz J; Spyckerelle Y; Henny J; Giordanella JP; Emmanuelli J
    Presse Med; 2001 Oct; 30(28):1389-93. PubMed ID: 11688202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Performance of the Hemoccult test in the screening of colorectal cancer and adenoma. Results of 5 screening campaigns in Saône-et-Loire].
    Tazi MA; Faivre J; Lejeune C; Benhamiche AM; Dassonville F
    Gastroenterol Clin Biol; 1999 May; 23(5):475-80. PubMed ID: 10429850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal cancer screening in Health Examination Centers.
    Steinmetz J; Spyckerelle Y; Guéguen R; Dupré C
    Gastroenterol Clin Biol; 2006; 30(6-7):832-7. PubMed ID: 16885866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal cancer mass screening event utilising quantitative faecal occult blood test.
    Chew MH; Suzanah N; Ho KS; Lim JF; Ooi BS; Tang CL; Eu KW
    Singapore Med J; 2009 Apr; 50(4):348-53. PubMed ID: 19421676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of colorectal cancer screening in Finland: experiences from the first three years of a public health programme.
    Malila N; Oivanen T; Hakama M
    Z Gastroenterol; 2008 Apr; 46 Suppl 1():S25-8. PubMed ID: 18368636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenomas and hyperplastic polyps in screening studies.
    Bech K; Kronborg O; Fenger C
    World J Surg; 1991; 15(1):7-13. PubMed ID: 1994609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low risk of colorectal cancer and advanced adenomas more than 10 years after negative colonoscopy.
    Brenner H; Haug U; Arndt V; Stegmaier C; Altenhofen L; Hoffmeister M
    Gastroenterology; 2010 Mar; 138(3):870-6. PubMed ID: 19909750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased incidence of colorectal adenomas in follow-up evaluation of patients with newly diagnosed hyperplastic polyps.
    Huang EH; Whelan RL; Gleason NR; Maeda JS; Terry MB; Lee SW; Neugut AI; Forde KA
    Surg Endosc; 2001 Jul; 15(7):646-8. PubMed ID: 11591960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mean number of adenomas per procedure should become the gold standard to measure the neoplasia yield of colonoscopy: a population-based cohort study.
    Denis B; Sauleau EA; Gendre I; Exbrayat C; Piette C; Dancourt V; Foll Y; Ait Hadad H; Bailly L; Perrin P
    Dig Liver Dis; 2014 Feb; 46(2):176-81. PubMed ID: 24054769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Colorectal Cancer Early Screening Program of Barcelona, Spain: Indicators of the first round of a program with participation of community pharmacies].
    Burón A; Grau J; Andreu M; Augé JM; Guayta-Escolies R; Barau M; Macià F; Castells A;
    Med Clin (Barc); 2015 Aug; 145(4):141-6. PubMed ID: 25073826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The first 3 years of national bowel cancer screening at a single UK tertiary centre.
    Gupta S; Saunders BP; Fraser C; Kennedy RH; Ignjatovic A; Sala S; Marshall S; Suzuki N; Vance M; Thomas-Gibson S
    Colorectal Dis; 2012 Feb; 14(2):166-73. PubMed ID: 21689280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained participation, colonoscopy uptake and adenoma detection rates over two rounds of the Tallaght-Trinity College colorectal cancer screening programme with the faecal immunological test.
    McNamara D; Leen R; Seng-Lee C; Shearer N; Crotty P; Neary P; Walsh P; Boran G; O'Morain C
    Eur J Gastroenterol Hepatol; 2014 Dec; 26(12):1415-21. PubMed ID: 25244415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of colorectal adenomas by a quantitative immunochemical faecal occult blood screening test depends on adenoma characteristics, development threshold used and number of tests performed.
    Rozen P; Levi Z; Hazazi R; Waked A; Vilkin A; Maoz E; Birkenfeld S; Leshno M; Niv Y
    Aliment Pharmacol Ther; 2009 Apr; 29(8):906-17. PubMed ID: 19183147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.